Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent

Showing results (711-720 of 1,192) with videos related to

Pageof 120
Sort By:
Blood|April 28, 2005
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceS Vincent Rajkumar, Robert A Kyle, Terry M Therneau, et al.
Blood|October 16, 2009
Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective studyHuei-Ting Tsai, Neil E Caporaso, Robert A Kyle, et al.
Circulation|June 4, 2008
Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarctionFelix M Gonzalez, Sruti Shiva, Pamela S Vincent, et al.
Regulatory Peptides|April 11, 2003
Rat progastrin processing yields peptides with altered potency at the CCK-B receptorDavid A Keire, S Vincent Wu, David L Diehl, et al.
Blood Cancer Journal|December 5, 2024
Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health databaseS Vincent Rajkumar, María-Victoria Mateos, Marcy Schaeffer, et al.
Mayo Clinic Proceedings|December 15, 2006
Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assaysJerry A Katzmann, Angela Dispenzieri, Robert A Kyle, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2013
Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaborationSergio Giralt, Philip L McCarthy, Kenneth C Anderson, et al.
Blood Cancer Journal|July 8, 2018
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trialsSikander Ailawadhi, Susanna Jacobus, Rachael Sexton, et al.
Journal of the American Society of Nephrology : JASN|April 23, 2011
Early reduction of serum-free light chains associates with renal recovery in myeloma kidneyColin A Hutchison, Paul Cockwell, Stephanie Stringer, et al.
Arthritis Research & Therapy|August 2, 2011
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the kneeStanley B Cohen, Susanna Proudman, Alan J Kivitz, et al.
Pageof 120

Showing results (711-720 of 1,192) with videos related to

Sort By:
Pageof 120
Blood|April 28, 2005
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceS Vincent Rajkumar, Robert A Kyle, Terry M Therneau, et al.
Blood|October 16, 2009
Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective studyHuei-Ting Tsai, Neil E Caporaso, Robert A Kyle, et al.
Circulation|June 4, 2008
Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarctionFelix M Gonzalez, Sruti Shiva, Pamela S Vincent, et al.
Regulatory Peptides|April 11, 2003
Rat progastrin processing yields peptides with altered potency at the CCK-B receptorDavid A Keire, S Vincent Wu, David L Diehl, et al.
Blood Cancer Journal|December 5, 2024
Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health databaseS Vincent Rajkumar, María-Victoria Mateos, Marcy Schaeffer, et al.
Mayo Clinic Proceedings|December 15, 2006
Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assaysJerry A Katzmann, Angela Dispenzieri, Robert A Kyle, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2013
Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaborationSergio Giralt, Philip L McCarthy, Kenneth C Anderson, et al.
Blood Cancer Journal|July 8, 2018
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trialsSikander Ailawadhi, Susanna Jacobus, Rachael Sexton, et al.
Journal of the American Society of Nephrology : JASN|April 23, 2011
Early reduction of serum-free light chains associates with renal recovery in myeloma kidneyColin A Hutchison, Paul Cockwell, Stephanie Stringer, et al.
Arthritis Research & Therapy|August 2, 2011
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the kneeStanley B Cohen, Susanna Proudman, Alan J Kivitz, et al.
Pageof 120